SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Best Web Messages of the Day -- Ignore unavailable to you. Want to Upgrade?


To: Steve Antonelli who wrote (5)2/16/2000 6:58:00 PM
From: Steve Antonelli  Read Replies (1) | Respond to of 20
 
02/16/00 AFFX - Biotech

AFFX in IBD
by: LyntonXLee 2/13/00 3:51 am
Msg: 3160 of 3177
AFFX is featured in the New America page of Monday's Investors Business Daily.

--------------------------------------------------------------------------------

messages.yahoo.com

Author: jaalkr Number: of 224
Subject: Competing technology? Date: 2/15/00 9:02 PM Email this to a Friend
Format for Printing
Post New ? Post Reply ? Reply Later Problem Post ? Recommend it!


Story in the New York Times 2/15, page D3, discusses a new genetics library technique that uses tiny polystyrene beads instead of a chip. The original scientific paper is published in the Proceedings of the National Academy of Sciences this week. IMHO, seems that this might become a cheaper and more efficient screening method than chip technology. Any thoughts?

boards.fool.com

Author: frflyer Number: of 224
Subject: Re: Is AFFX the next Snapple? Date: 2/16/00 3:35 AM Email this to a Friend
Format for Printing
Post New ? Post Reply ? Reply Later Problem Post ? Recommend it!


Yowman;
The PE Corp you are talking about, is not Perkin Elmer. PE Corp, comprised of PE Biosystems(PEB) and
PE Celera(CRA), sold off the Perkin Elmer analytical instruments business and the name Perkin Elmer.

PE Biosystems has a market cap of about $15B-$17B
And I believe it is they who have the PCR patents.

There is no stock for PE Corp, just the two tracking stocks.

frflyer

boards.fool.com

Author: frflyer Number: of 224
Subject: Re: Competing technology? Date: 2/16/00 3:48 AM Email this to a Friend
Format for Printing
Post New ? Post Reply ? Reply Later Problem Post ? Recommend it!


jaalkr;

There are several companies using bead technology. (microspheres)

Ilumina a private company uses beads with fiber optics
Luminex similar to Ilumina, uses diode lasers; is going public soon (LMNX)

Lynx (LYNX) uses beads in a different way.
Symx ( ? )also uses bead technology

I mix microspheres with epoxy to fair the hull of a boat, but that's a another story.

boards.fool.com

By: RedDot
Reply To: None Monday, 24 Jan 2000 at 9:27 AM EST
Post # of 106


Look at NGEN.....piece of article below....Like

Affymetrix, Nanogen applies semiconductor manufacturing advances to DNA diagnostics; however, its technologies are very different. Whereas Affymetrix uses a nonelectronic photolithographic process to hybridize genes, Nanogen electronically addresses DNA to force hybridization. The size of an Intel 286 chip, Nanogen's Apex draws DNA strand-mates together with a positive electronic charge. Then it switches to a negative charge, and only the hybridized strands remain in an embrace. Hybridization with Nanogen's Apex is faster than with Affymetrix's GeneChip. Another significant difference is that Apex is essentially an ASIC, or reconfigurable electronic device, the likes of which are manufactured by the millions at Texas Instruments and elsewhere. Apex's DNA probes can thus be rearranged on the fly by software to test for new diseases.

ragingbull.com

By: proteomics
Reply To: 99 by stardance Thursday, 3 Feb 2000 at 7:24 PM EST
Post # of 106


Important info? Not!

Affymetrix has NOTHING to do with gene therapy! They make chips that can be used, potentially, to diagnose a host of illnesses. The chips allow doctors to tailor a patients treatment to their genetic makeup, reducing the side effects and increasing the effitiveness. Gene therapy is a whole other ball game, and not one that affymetrix is even looking towards. For affymetrix, think perfect diagnostics. Not therapy.

ragingbull.com